These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

681 related articles for article (PubMed ID: 18572499)

  • 1. [Prevalence of anti-HAV antibodies in Warsaw population].
    Janaszek-Seydlitz W; Bucholc B; Wiatrzyk A
    Przegl Epidemiol; 2007; 61(4):675-82. PubMed ID: 18572499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia.
    Jaber SM
    Saudi Med J; 2006 Oct; 27(10):1515-22. PubMed ID: 17013474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations.
    Ceyhan M; Yildirim I; Kurt N; Uysal G; Dikici B; Ecevit C; Aydogan A; Koc A; Yasa O; Köseoğlu M; Onal K; Hacimustafaoglu M; Celebi S
    J Viral Hepat; 2008 Oct; 15 Suppl 2():69-72. PubMed ID: 18837839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.
    Gutiérrez Domingo I; Pascasio Acevedo JM; Alcalde Vargas A; Ramos Cuadra A; Ferrer Ríos MT; Sousa Martín JM; Sayago Mota M; Giráldez Gallego A; Suárez Artacho G
    Transplant Proc; 2012; 44(6):1502-4. PubMed ID: 22841196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents].
    González-Huezo MS; Sánchez-Avila F; García Mayol M; Castro Narro G; Sixtos S; Lisker-Melman M; Kershenobich D
    Rev Gastroenterol Mex; 2003; 68(4):271-6. PubMed ID: 15125329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Seroprevalence of antibodies against hepatitis A virus and hepatitis B virus in nonvaccinated adult population over 40 years of age].
    Chlíbek R; Cecetková B; Smetana J; Prymula R; Kohl I
    Epidemiol Mikrobiol Imunol; 2006 Aug; 55(3):99-104. PubMed ID: 16970073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine induced Hepatitis A and B protection in children at risk for cystic fibrosis associated liver disease.
    Shapiro AJ; Esther CR; Leigh MW; Dellon EP
    Vaccine; 2013 Jan; 31(6):906-11. PubMed ID: 23261047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The prevalence of markers for the hepatitis A and B viruses in the population of Gijón between 6 and 25 years old].
    Suárez A; Navascués CA; García R; Peredo B; Miguel D; Menéndez MT; Saro C; Román F
    Med Clin (Barc); 1996 Apr; 106(13):491-4. PubMed ID: 8992130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis A seroprevalence in children and adults in Kiev City, Ukraine.
    Moisseeva AV; Marichev IL; Biloschitchkay NA; Pavlenko KI; Novik LV; Kovinko LV; Lyabis OI; Houillon G; Rasuli AM
    J Viral Hepat; 2008 Oct; 15 Suppl 2():43-6. PubMed ID: 18837833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatitis B in Poland in 2001].
    Kuszewski K; Czarkowski MP
    Przegl Epidemiol; 2003; 57(1):117-23. PubMed ID: 12926317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
    Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
    Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of hepatitis A virus antibodies among a sample of Egyptian children.
    Al-Aziz AM; Awad MA
    East Mediterr Health J; 2008; 14(5):1028-35. PubMed ID: 19161074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy.
    Ahmed M; Munshi SU; Nessa A; Ullah MS; Tabassum S; Islam MN
    Indian J Med Microbiol; 2009; 27(1):48-50. PubMed ID: 19172060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody titers and response to vaccination against hepatitis A and B in pediatric patients with portal hypertension.
    Rosa MN; Hessel G; Alves De Tommaso AM
    Acta Gastroenterol Latinoam; 2008 Sep; 38(3):187-93. PubMed ID: 18979898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [How protective is the immunization against viral hepatitis B prospectively? Seroprevalence study on viral hepatitis B infection].
    Bocşan IS; Gocan G; Ursu L; Brumboiu MI; Soşa I; Simionca L; Sava A; Olaru O; Păştina I
    Rev Med Chir Soc Med Nat Iasi; 2005; 109(1):124-30. PubMed ID: 16607840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatitis B in Poland in 2000].
    Kuszewski K; Swiderska H
    Przegl Epidemiol; 2002; 56(2):319-23. PubMed ID: 12371366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunity to hepatitis A and hepatitis B in Indian and Chinese immigrants seen in a travel clinic in Massachusetts, United States.
    Ooi WW; Gallagher A; Chen LH
    J Travel Med; 2006; 13(4):212-8. PubMed ID: 16884403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatitis A in Poland in 2008].
    Baumann A
    Przegl Epidemiol; 2010; 64(2):235-7. PubMed ID: 20731228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence of anti-HAV antibodies in selected groups of children].
    Ryszkowska A; Gładysz A; Inglot M; Molin I
    Przegl Epidemiol; 2000; 54(3-4):375-83. PubMed ID: 11349601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroepidemiology of hepatitis A and hepatitis B virus in Luxembourg.
    Mossong J; Putz L; Patiny S; Schneider F
    Epidemiol Infect; 2006 Aug; 134(4):808-13. PubMed ID: 16436219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.